AYLA

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Acelrx (ACRX – Research Report) and Ayala Pharmaceuticals (AYLA – Research Report). Acelrx (ACRX) In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Acelrx. The company's shares closed last Tuesday at $0.28, close to its 52-week low of $0.27. According to TipRanks.com, Arce is a 4-star analyst with an average return of -27.1% and a 24.7% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Oncternal Therapeutics, and Oramed Pharmaceuticals.
https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-acelrx-acrx-and-ayala-pharmaceuticals-ayla?utm_source=advfn.com&utm_medium=referral